Van Broekhoven, Christina; Parish, Christopher; Vassiliou, G; Altin, Joseph
The genetic modification of cells to develop cell-based vaccines and to modulate immune responses in vivo can be risky and inconvenient to perform in clinical situations. A novel chelator lipid, nitrilotriacetic acid di- tetradecylamine (NTA-DTDA) that, via the NTA group has high affinity for 6His peptide, was used to directly anchor recombinant forms of T cell costimulatory molecules containing a C-terminal 6-His sequence onto tumor cell surfaces. Initial experiments using murine P815 tumor...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.